Prof. Michał Zarobkiewicz

Michał Zarobkiewicz

Immunologist and research group leader

My research focuses on γδ T cells in cancer, particularly chronic lymphocytic leukaemia, and on their potential in cellular immunotherapy.

Academic career

  1. 2026

    Habilitation

    Medical University of Lublin

  2. 2018–2022

    PhD

    Medical University of Lublin

  3. 2020–2021

    Research stay in Kiel

    Institute of Immunology, University Hospital Schleswig-Holstein · Prof. Dieter Kabelitz’s group

  4. 2012–2018

    Medical degree (MD)

    Medical University of Lublin

Research metrics

As of May 2025

Publications
47
Combined impact factor
131.375
h-index
14

Editorial work

Editorial board member

Scientific Reports, BIOCELL and Discover Medicine

Review editor

Frontiers in Immunology and Frontiers in Microbiology

BioEastern

I co-founded BioEastern Sp. z o.o., a former Polish biotechnology company specialising in immunology and flow cytometry.

BioEastern logo